ArticleAdvances in experimental medicine and biology2026
Mental Health and Quality of Life in Perimenopausal and Menopausal Women : Quality of Life in Women.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although menopause is a normal process, it causes a number of symptoms that affect women's health and quality of life (QoL). Furthermore, mental health problems, including depression and anxiety, in peri- and postmenopausal women are a major public health concern. The aim of this research study was to investigate menopausal symptoms and their association with mental health and quality of life. A cross-sectional study involving 78 women aged 36-58 years who were in the perimenopause or menopause was conducted. The instruments used were the Greek versions of the Menopausal Rating Scale (MRS), the Depression, Stress and Anxiety Assessment Scale (DASS-21), and the World Health Organization Quality of Life Scale (WHOQoL-BREF). According to the results, menopausal symptoms were found to be of low overall severity, a small proportion (7.8%) have mild depressive symptoms and mild anxiety symptoms (9.1%), and all scales of women's quality of life show high mean values, indicating a good to fairly good quality of life. The most important findings of the study are the statistically significant negative correlations between almost all dimensions of the DASS-21 scale and the WHOQoL-BREF dimensions, and between almost all dimensions of the MRS scale and the dimensions of the WHOQOL-BREF scale. In our study, menopause was not associated with poor quality of life at a general level; however, it was confirmed to have a statistically significant negative effect on quality of life, depending on the severity of symptoms and the coexistence of other complications such as depression.
Indexed as
Identifiers
41273561What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.